MedTrace Logo

Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

NCT00000262 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-27

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.

Conditions

  • Opioid-Related Disorders
  • Substance-Related Disorders

Interventions

DRUG

30% Nitrous oxide

DRUG

0.4% Sevoflurane

DRUG

0.2% sevoflurane

OTHER

Placebo

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • James Zacny, Ph.D. · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-11-30
Primary Completion
1999-02-28
Completion
1999-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000262 on ClinicalTrials.gov